Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a global pharmaceutical leader focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world. Allergan markets a portfolio of leading brands andbest-in-class products primarily focused on four key therapeutic areas including medical aesthetics, eye care, central nervous system and gastroenterology. As part of its approach to delivering innovation for better patient care, Allergan has built one of the broadest pharmaceutical and device research and development pipelines in the industry.
Company profile
Website
CEO
Brenton L. Saunders
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Actavis Ltd, Actavis plc
SEC CIK
Corporate docs
Subsidiaries
AGN International Inc. • AGN Kythera, L.P. • AGN Labs LLC • AGN LLC • AGN Sundry LLC • Akarna Therapeutics, Limited • Allergan WC 1 S.a r.l. • Allergan (Chengdu) Medical Aesthetics Clinic Co., Ltd. • Allergan (Thailand) Limited • Allergan AG ...
Latest filings (excl ownership)
15-12B
Securities registration termination
21 May 20
EFFECT
Notice of effectiveness
19 May 20
EFFECT
Notice of effectiveness
19 May 20
EFFECT
Notice of effectiveness
19 May 20
EFFECT
Notice of effectiveness
19 May 20
POS AM
Prospectus update (post-effective amendment)
14 May 20
POS AM
Prospectus update (post-effective amendment)
14 May 20
POS AM
Prospectus update (post-effective amendment)
14 May 20
POSASR
Automatic shelf registration (post-effective amendment)
14 May 20
POS AM
Prospectus update (post-effective amendment)
14 May 20
Latest ownership filings
Institutional ownership, Q2 2023
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|